Tetra Bio-Pharma Creates the ENJOUCA Business Unit
Tetra Bio-Pharma Creates the ENJOUCA Business Unit OTTAWA, ON / ACCESSWIRE / February 3, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development announced today the creation of a wholly-owned subsidiary called ENJOUCA. Jurisdictions differ greatly in terms of regulatory requirements surrounding medical cannabis, which means that in some territories, QIXLEEF can be commercialized as a medical cannabis product. As a result, Tetra's strategy is to launch QIXLEEF under the trademark, ENJOUCA as ...
Source: finanznachrichten.de